Avinger shares are trading higher after the company announced the full commercial launch of its Pantheris LV image-guided atherectomy device.
Portfolio Pulse from Benzinga Newsdesk
Avinger shares rose following the full commercial launch of its Pantheris LV image-guided atherectomy device.
August 20, 2024 | 12:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avinger shares increased due to the full commercial launch of its Pantheris LV image-guided atherectomy device, indicating positive market reception.
The launch of a new product, especially in the medical device sector, often leads to increased investor interest and potential stock price appreciation. The positive market reaction to the Pantheris LV device suggests confidence in its commercial potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100